Assuming Peak Year Performance
A company reports record revenue and profit one year. It grows 40% top-line and 45% bottom-line. The stock jumps 35% on the results. Investors extrapolate: "If it can do this once, it can do this again." They run a discounted cash flow model assuming 40% annual growth for the next five years. They conclude the stock is worth $200. It trades at $95. They buy, convinced they have found a bargain.
Two years later, growth has slowed to 15% annually. The valuation compressed. The stock is now $65. The investor is underwater and confused. They had a model. The model said $200. Why did it fail?
The model failed because it assumed a peak year—the one exceptional year in the company's history—would repeat indefinitely. This is one of the most common and expensive valuation mistakes.
Peak years are anomalies, not the baseline. Assuming they continue is a guaranteed path to overpaying for stocks.
Key takeaways
- Peak year revenue or profit is a ceiling, not a floor. It occurs once because of temporary tailwinds: a new product launch, one-time demand, a market shift, exceptional execution.
- Assuming a peak year repeats creates a "growth forever" illusion that justifies inflated valuations.
- Most companies revert to a more modest baseline growth rate within two to three years as markets mature, competition intensifies, and headwinds return.
- The bigger the gap between peak year and historical average growth, the more likely reversion is coming.
- Valuation models that ignore reversion to the mean systematically overvalue growing companies.
What a peak year actually is
A peak year is rarely a sign of future stability. It is typically the collision of multiple favorable conditions, most of which are temporary.
Consider a software company that grew 60% in 2023. What actually happened?
- A major new product launched and exceeded expectations (one-time event).
- An acquisition added a new customer base overnight (non-repeatable).
- A competitor had a security breach, and customers switched (temporary advantage).
- The company achieved 500 net new enterprise customers, the most in its history (exceptional execution).
- Interest rates fell, and customers prioritized software investments (macro tailwind).
- The company raised prices 15%, and customers accepted (temporary pricing power).
In 2024, what happened?
- The new product launch is no longer new; growth from it normalized.
- The acquisition integration is complete; it no longer contributes unusual growth.
- Competitors fixed their security issues; customers stopped switching.
- Finding the next 500 enterprise customers is harder; the addressable market is getting saturated.
- Interest rates rose, and customers cut spending (macro headwind).
- Customers resisted the second round of price increases.
Growth fell to 25%.
The company is not failing. It is normalizing. But an investor who modeled 60% growth for five years just experienced a 58% miss. The stock repriced accordingly.
The temptation to extrapolate the exceptional year
When a company has an exceptional year, it is almost irresistible to extrapolate. The numbers are real. The company just proved it can achieve that level of performance. Why can't it do it again?
Because the conditions that enabled peak performance were rare. Here is the fatal assumption: "If the company can achieve X once, it can achieve X again and again." This is false. A runner can run a sub-4-minute mile once in his career under perfect conditions: ideal weather, perfect pacing, peak fitness, wind assistance. He cannot run sub-4 minutes every week.
Companies work the same way. A software company can book a $50 million deal once if a large customer's budget cycle aligns with their product launch and they have a rare moment of executive alignment. But that deal is not repeatable. Most customers cannot absorb new technology at that pace. Most budgets are planned years in advance.
Yet analysts and investors routinely build financial models that assume peak-year performance repeats. Here is why:
- Simplicity. It is easier to assume next year looks like last year than to think through multiple scenarios.
- Optimism bias. People believe good outcomes will persist while bad outcomes are temporary.
- Recency bias. The most recent year is the freshest in memory, and so it feels like the new baseline.
- Analyst incentives. Bull-case models get more attention; bear-case models are less popular.
The result is valuations that are systematically too high for growth companies.
How peak-year assumptions destroy value
Consider a real-world example: a biotech company with two drugs in late-stage clinical trials. One drug was approved by the FDA ahead of schedule. Within one year, it achieved $300 million in peak sales—beyond expectations. The company had never launched a successful drug before. Analysts extrapolated.
Model assumptions:
- Year 1: $300M in drug sales
- Year 2-5: $300M growing at 10% annually
- Terminal growth: 3%
- Result: Valuation of $8 billion
The company was valued at $8 billion on the basis that one drug would generate perpetual revenue.
What actually happened:
- Year 2: A competitor launched a better drug. The original drug's growth stalled at $250M.
- Year 3: A safety signal emerged (a small subset of patients experienced adverse effects). Sales declined to $180M.
- Year 5: Cumulative sales had reached $400M total—not $400M annually.
The stock fell from $120 to $35. Investors who believed the model were devastated.
The error: assuming a peak year repeats and applies to a single product indefinitely. The peak year included the novelty bounce of a new drug. That bounce is one-time.
The difference between peak year and equilibrium growth
Every company has an equilibrium growth rate—the rate it can sustain indefinitely without exhausting markets, without competitive threats becoming overwhelming, without running out of capital.
For mature companies, equilibrium growth is usually 3-8% annually—roughly aligned with GDP growth plus inflation.
For growth companies, equilibrium growth might be 15-30% annually—because they are still addressing large addressable markets.
For high-growth companies, equilibrium growth might be 30-50% annually—but only until the market matures or competition intensifies.
A peak year is a deviation above equilibrium, not equilibrium itself. It occurs when:
- A new product launches and captures more demand than expected.
- A major customer or market opens unexpectedly.
- Pricing power increases temporarily due to supply constraints.
- A competitor exits or stumbles.
- A macro tailwind accelerates spending.
After the peak year, growth reverts toward equilibrium. It might take one, two, or five years, but reversion almost always happens.
The investor's job is to estimate what the equilibrium growth rate actually is, not to assume the peak year repeats forever.
The high-growth company trap
High-growth companies are especially vulnerable to peak-year extrapolation because each year of explosive growth strengthens the narrative that growth will continue. A company growing 50% a year feels like it will always grow 50% a year.
But the mathematics of growth are cruel. If a company with $100 million in revenue grows 50% annually, it becomes a $150 million company in year 1, $225 million in year 2, $337 million in year 3, and $760 million in year 5. At some point, the market cannot absorb that much additional volume. Growth slows.
For example, Zoom grew 326% in 2020—its peak year as enterprises shifted to remote work. Investors assumed Zoom would dominate video conferencing forever. The stock shot to $580. But Zoom's growth slowed to 55% in 2021, 35% in 2022, and 18% in 2023. The stock is now $32—lower than the peak despite being far more profitable. Peak-year extrapolation broke valuations.
The question to ask: Is this year's growth rate sustainable? Or is it inflated by a one-time event?
How to detect peak-year traps
1. Compare current year growth to historical growth. If this year's growth is the highest in the company's history by a large margin (50%+ higher), it might be peak-year inflated. Ask why growth spiked. Is the reason temporary?
2. Look at the growth rate trend. Is growth accelerating, stable, or decelerating?
- Accelerating (20% → 30% → 40%) suggests the company is gaining momentum; extrapolating might be reasonable.
- Stable (40% → 40% → 40%) suggests the business has found equilibrium; extrapolating is safer.
- Decelerating (40% → 35% → 30%) suggests peak year already happened; extrapolating high growth is wrong.
3. Analyze the drivers. What drove the peak year? Are those drivers repeatable?
- New product launch: One-time event. Growth will normalize.
- Expansion into a new market: Repeatable, but harder each market. Growth will slow.
- Pricing increases: Temporary unless the company has enduring pricing power.
- Acquisition: One-time contribution; organic growth might be slower.
- Market share gains: Repeatable but diminishing as the company takes more share.
4. Check for mean reversion. What is the company's average growth rate over the past 5-10 years? If this year is an outlier far above the average, reversion to the mean is likely coming.
The problem with "hockey stick" projections
Many analysts build models that assume relatively modest growth for the next two to three years, then hockey-stick upward once a key catalyst arrives. For example: "Growth will be 15% for three years, then 40% once the new product launches." This is a form of peak-year assumption—it bakes in a peak-year scenario (the 40% growth) without questioning whether it will materialize and whether it will sustain.
The hockey-stick assumption is almost always wrong because:
- The catalyst often does not arrive on schedule.
- When it arrives, its impact is usually smaller than expected.
- When it does impact growth, competitors respond, limiting the upside.
- The high-growth scenario is priced into the stock long before the catalyst arrives; when it does arrive, the stock is already at the high price.
A better approach: model base-case growth (what is likely), downside growth (if things go wrong), and upside growth (if things go better than expected). Then weight the scenarios by probability. This forces you to explicitly acknowledge that peak years are outliers, not base cases.
Real-world example: the Tesla trap
Tesla grew vehicle deliveries 71% in 2020, 88% in 2021, and 40% in 2022. If analysts extrapolated the 71% and 88% growth rates, they would have projected Tesla would deliver 50+ million vehicles by 2030. This was impossible; global vehicle sales are only 80 million annually.
Yet during that period, Tesla's valuation reached $1 trillion despite delivering only 1.8 million vehicles per year—a valuation implying extreme growth rates for the next decade. Peak-year growth was being assumed as perpetual.
In reality, Tesla's growth decelerated to 38% in 2023 and 2% in 2024 as the addressable market was substantially tapped. Investors who extrapolated peak-year growth overpaid by a factor of 2-3x.
Common mistakes with peak-year assumptions
Mistake 1: Assuming the peak year is the new baseline. It is not. It is an outlier above the baseline.
Mistake 2: Confusing "record year" with "sustainable year." A record year is by definition exceptional. Exceptional things do not repeat every year.
Mistake 3: Failing to adjust for market saturation. Even if a company can grow 40% annually, it cannot do so forever. Markets fill up. Competitors respond. Growth must decelerate.
Mistake 4: Using analyst consensus models as a sanity check. If every analyst is extrapolating peak-year growth, that does not validate the assumption; it just means everyone is making the same mistake.
FAQ
Q: How far into the future should I model high growth rates?
A: Only as far as the company's competitive advantage and market size support. If the company has a $50 billion addressable market and is currently at $2 billion in revenue, it might support 25-30% growth for five to seven years. But once the company nears the market ceiling, growth must decelerate. Be explicit about when growth decelerates and by how much.
Q: If a company has achieved 40% growth for three consecutive years, can I assume it will achieve 40% for the next five?
A: Maybe. If the company's market share is not saturated and it continues gaining share, three years of consistent growth might indicate a sustainable trend. But check whether growth is decelerating (40% to 35% to 30%) or stable (40% to 40% to 40%). Deceleration is a leading indicator of reversion.
Q: What if the company says in their guidance that they expect peak-year growth to repeat?
A: Do not believe management guidance about perpetual growth. Management is incentivized to be optimistic. Instead, analyze the market size, competitive position, and historical patterns. If the fundamentals support the guidance, it might be reasonable. If the guidance implies the company will grow faster than the entire market for the next decade, it is unrealistic.
Q: Is there a quantitative way to check for peak-year overvaluation?
A: Yes. Compare the implied growth rate in the stock's valuation (derived from DCF analysis working backward from price) to the company's actual historical and projected growth rates. If the implied growth rate is far higher than what is achievable, the stock is priced for peak-year continuation.
Q: Should I ever buy a stock that is priced for peak-year growth?
A: Only if you have strong conviction that the peak year is repeatable or that a new sustainable high-growth platform is emerging. This is a bet, not an analysis. Price it accordingly—size smaller positions; demand a bigger margin of safety.
Q: What did Zoom, Peloton, and Zoom's best customers do wrong?
A: They priced their stocks for peak-year growth (pandemic-driven surge) to continue indefinitely. When growth normalized, the stocks crashed. The lesson: never assume that extraordinary events (like a pandemic) that accelerated growth will persist in their abnormality.
Related concepts
- Building a discounted cash flow model
- Terminal growth rate and its pitfalls
- Reversion to the mean
- Market saturation and growth deceleration
- High-growth company valuation
Summary
Peak-year performance is not a baseline; it is an anomaly. When a company achieves exceptional growth in one year, it is usually due to temporary tailwinds—a new product launch, a market surge, a competitor stumble, or one-time customer wins. Assuming that peak year repeats indefinitely creates valuations that are systematically too high. Instead, investors should analyze whether the peak year's drivers are repeatable and sustainable. If they are temporary, growth will revert toward historical averages or industry-level growth. Most growth companies revert to slower equilibrium growth within two to five years. A valuation model that assumes otherwise is a value trap disguised as opportunity. The stronger the conviction in perpetual peak-year growth, the less cautious the investor is being.